Controlled Substance Management in Chronic Pain, Softcover reprint of the original 1st ed. 2016
A Balanced Approach

Coordinators: Staats Peter S., Silverman Sanford M.

Language: English

89.66 €

In Print (Delivery period: 15 days).

Add to cartAdd to cart
Controlled Substance Management in Chronic Pain
Publication date:
Support: Print on demand

84.39 €

In Print (Delivery period: 15 days).

Add to cartAdd to cart
Controlled Substance Management in Chronic Pain
Publication date:
Support: Print on demand

This comprehensive guide covers prescribing controlled substances for patients with acute or chronic pain and provides a balanced discussion on appropriate treatment, addiction, safety and complications.  Chapters feature evidence-based strategies and clinical modalities that address diagnostic challenges, treatment guidance, alternatives to opioid management and the significant legal risks within the current regulatory environment.  Authored by leaders in pain medicine, physicians and appropriate health care professionals will find Controlled Substance Management in Chronic Pain to be an indispensable resource. 

1 Scope of the pain problem.- 2 Scope of the problem: Intersection of chronic pain and addiction.- 3 Evidence-based treatment for chronic pain with opioids.- 4 Opioid pharmacology.- 5 Pharmacokinetics.- 6 Benzodiazepines, Alcohol and Stimulant Use in Combination with Opioid Use.- 7 Marijuana and cannabinoids for pain.- 8 Adjuvant agents in chronic pain therapy.- 9 Complications of opioid therapy.- 10 Risk mitigation strategies.- 11 Naloxone Treatment of Opioid Overdose.- 12 From Patient Evaluation to Opioid Overdose Prevention: Ten Steps to Make the Law Work for You and Your Patients.- 13 Treating the difficult patient.- 14 Controlled Substance Management: Exit Strategies for the Pain Practitioner.- 15 Alternatives to opiates in the management of non-cancer related pain.- Appendix A: American Society of Interventional Pain Physicians (ASIPP) Guidelines for Responsible Opioid Prescribing in Chronic Non-Cancer Pain.- Appendix B: Sample Opioid Agreement/Informed Consent.- Appendix C: Opioid Risk Tool.- Appendix D: Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP®-R).- Appendix E: McGill Pain Questionnaire.

Peter S. Staats, MD, MBA, FIPP ABIPP
President, American Society of Interventional Pain Physicians
Johns Hopkins University
Department of Anesthesiology and Critical Care, and Department of Oncology
Premier Pain Centers 
Shrewsbury, NJ 

 
 
Sanford M. Silverman, MD, DABPM, DABAM
CEO and Medical Director of Comprehensive Pain Medicine, Pompano Beach, FL<
Department of Anesthesiology, Affiliate Assistant Professor of Clinical Biomedical Science, Charles E. Schmidt College of Medicine, Florida Atlantic University
Department of Surgery,  Boca Raton Regional Hospital
Department of Surgery,  Broward North Medical Center

A comprehensive resource for physicians who evaluate patients with acute and chronic pain Provides guidance and presents risks of prescribing controlled substances Current regulatory environment, legal aspects and other challenges are discussed Includes supplementary material: sn.pub/extras